ChondroFiller injection for talar dome cartilage defectsChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.ChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
ChondroFiller injection side effects and safetySwelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.Swelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.
ChondroFiller Injection Cost in the UKA ChondroFiller injection costs £3,000 for one box, £5,500 for two, and £8,000 for three; the volume required depends on cartilage defect anatomy, not the joint being treated.A ChondroFiller injection costs £3,000 for one box, £5,500 for two, and £8,000 for three; the volume required depends on cartilage defect anatomy, not the joint being treated.
ChondroFiller Injection Evidence Patients Should WeighInjected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
Knee cartilage repair versus stem cell therapyEstablished cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.Established cartilage repair using autologous chondrocytes shows 10–17 year durability for focal knee defects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
ChondroFiller injection cost in the UKChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.ChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.
ChondroFiller injection for knee cartilage defectsThe injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
ChondroFiller injection safety and the questions to askChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
ChondroFiller injection for ankle cartilage defectsChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.